Gene Query: PPCS

Dataset Description Geneva Score
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 19.88
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 16.2
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 13.54
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 13.31
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 12.82
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 11.52
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 11.52
MOF acetyl transferase regulates transcription and respiration in mitochondria 10.82
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 10.09
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 9.65
Stem and effector CD8 T-cells from human cancers 9.54
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 9.14
Effect of CHKA knockdown on C4-2 cell transcriptome 9.0
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 8.84
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 8.75
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 8.75
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 8.54
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 8.49
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 8.04
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 8.0
Dtx3L and Androgen Signaling in Prostate Cancer 7.99
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 7.62
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.6
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.6
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 7.57
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 7.55
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 7.27
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 7.24
JunB control of keratinocyte-mediated inflammation [RNA-seq] 7.22
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 7.22
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 7.19
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 7.19
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 7.16
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 7.05
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 6.87
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 6.47
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 6.41
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 6.39
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 6.19
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 5.92
Pharmacologic inhibition of STAT5 in AML 5.81
RNAseq Study in CC-671 Treated Cal-51 Cells 5.78
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 5.73
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 5.64
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 5.64
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 5.62
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 5.57
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 5.57
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 5.57
Identification of renal resident macrophages across species 5.56
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 5.54
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 5.48
TCF7L1 knockdown in pancreatic cancer 5.47
Gene expression in PANC1 cells treated with Rakicidin 5.39
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 5.33
CROP-Seq in Primary Human T Cells 5.24
Genome-wide functional assessment of enhancer activities in the human genome 5.23
DART-seq: an antibody-free method for global m6A detection 5.2
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 5.18
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.16
mRNA expression profile of Lymphocytes 5.09
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.02
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 5.01
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 5.0
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 4.99
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 4.9
SUV420H2 knockdown in PANC-1 4.84
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 4.78
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 4.78
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 4.76
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 4.72
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 4.72
Single-nucleotide-resolution mapping of HBV promoters using CAGE 4.71
Trans-differentiation of human adult peripheral blood T cells into neurons 4.7
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 4.69
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 4.68
miRNAs affected by antagomiR-17 treatment 4.62
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 4.53
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 4.52
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 4.51
Lipid degradation promotes prostate cancer cell survival 4.5
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 4.5
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 4.48
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 4.48
The evolution of N6-methyladenosine in primates 4.47
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 4.45
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 4.45
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 4.45
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 4.39
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 4.38
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 4.38
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 4.36
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 4.35
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 4.3
Gene expression analysis of immortalized human liver progenitor-like cells in culture 4.29
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 4.27
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 4.27
Integrating single-cell transcriptomic data across different conditions, technologies, and species 4.26
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 4.26
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 4.21
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 4.21
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 4.13
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.12
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 4.11
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 4.09
ML29755 RNA-seq data 4.09
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 4.05
The regulartory role of ZCCHC24 in splicing machinery 4.04
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 4.02
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 4.02
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 3.99
RNA-seq of YB5 cells treated with Proscillaridin A 3.99
Generating Patterned Kidney Organoids for Studying Development and Diseases 3.99
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 3.98
Transcriptional profiling of microglia; current state of the art and future perspectives 3.98
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 3.96
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.88
CDK4/6 inhibitor resistance in prostate cancer 3.87
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.82
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.81
Oncogenic MYC induces a dependency on the spliceosome in human cancer 3.81
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 3.81
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 3.79
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 3.79
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 3.78
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.78
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.77
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 3.75
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 3.75
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 3.74
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 3.74
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 3.73
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.64
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 3.61
Effect of PBK knockdown on C4-2 cell transcriptome 3.6
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 3.59
Direct Isolation and Characterization of Human Nephron Progenitors. 3.58
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 3.58
Gene expression changes associated with resistance to tagraxofusp (SL-401) 3.58
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 3.57
Integrin signaling regulates YAP/TAZ to control skin homeostasis 3.56
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 3.53
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 3.51
Primary human trophoblast from term placenta 3.51
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.5
Loss of CREBBP results in gene expression repression in lymphoma cells 3.5
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 3.49
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 3.49
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 3.48
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 3.45
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 3.45
Non-coding regions are the main source of tumor-specific antigens [human] 3.44
Non-coding regions are the main source of tumor-specific antigens 3.44
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 3.44
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 3.42
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 3.4
MARCKS and lnc-MARCKS act as inflammation regulators 3.39
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 3.32
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 3.32
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 3.29
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 3.26
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 3.24
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.23
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 3.21
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 3.19
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 3.17
Rorc disruption in human FG pancreatic cancer cells 3.16
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.15
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.14
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.14
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 3.1
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 3.1
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 3.08
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 3.07
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 3.07
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 3.06
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 3.05
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.02
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.02
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 3.01
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 3.0
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 2.99
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 2.99
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 2.98
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 2.98
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 2.97
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 2.97
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 2.95
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 2.95
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 2.95
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 2.95
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 2.94
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 2.94
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 2.91
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 2.9
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 2.9
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.9
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.9
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.89
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 2.89
Chromatin-informed inference of transcriptional programs in gynecologic cancers 2.89
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 2.89
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 2.88
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 2.87
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 2.85
H1609088 Human RNA-Sequencing 2.84
RNA-seq analyisis of PUM2 knockout cells 2.83
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 2.81
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.8
Gene expression analysis of the impact of TDP-43 knockout in human cells. 2.8
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 2.78
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 2.78
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 2.77
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.74
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 2.73
HNRNPM-regulated splicing dependencies in prostate cancer 2.71
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 2.71
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.71
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.71
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 2.7
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 2.7
Transcription elongation regulates genome 3D structure 2.7
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.7
Landscape and variation of RNA secondary structure across the human transcriptome 2.69
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 2.68
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 2.68
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 2.67
Single-cell analysis of adult human ovary using 10X genomics 2.67
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 2.66
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 2.66
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 2.64
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.64
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 2.64
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.6
RNA-seq of IL-4 stimulated human keratinocytes 2.57
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.55
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 2.55
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 2.55
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 2.54
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.51
RNA sequencing of matched nephrectomy samples [RNA-seq] 2.51
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 2.51
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 2.5
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.46
MeRIP-seq for heat shock in B-cell lymphoma cells 2.44
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.44
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 2.43
RNA-Seq with and without RNase treatment in PCa cell lines 2.43
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 2.42
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 2.42
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 2.41
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 2.4
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.39
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 2.38
hnRNP C is a key regulator of protein synthesis in mitosis 2.38
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 2.38
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.37
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 2.36
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 2.35
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.34
Transcriptome of diurnal human blood neutrophils 2.33
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 2.32
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 2.31
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 2.31
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 2.3
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 2.28
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.27
Transcriptional landscape changes during human embryonic stem cell derivation 2.27
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.25
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.23
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.23
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 2.22
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 2.21
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.19
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 2.14
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 2.12
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.11
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.08
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 2.07
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 2.07
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 2.07
HNRNPL and its RNA Targets in Prostate Cancer 2.07
RNA-seq of naive and primed ES cells (NHSM) 2.05
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 2.05
RNA-seq of cancer cell lines treated with T-025 2.03
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.02
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 2.01
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.0
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 2.0
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 1.9
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.89
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 1.89
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.89
Gene expression signatures of innate lymphoid cells from human blood 1.87
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 1.85
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.85
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 1.84
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.84
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 1.83
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 1.83
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 1.83
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 1.81
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.78
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 1.75
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.73
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.72
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 1.72
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 1.71
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.7
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.69
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.68
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 1.67
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 1.67
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 1.66
Transcriptional profile in human S. haematobium infection 1.65
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.65
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.65
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.65
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.59
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.59
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 1.58
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 1.58
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.55
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.55
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 1.53
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.53
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 1.52
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 1.52
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 1.5
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 1.5
MAIT cell RNA sequencing 1.5
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 1.49
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 1.48
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.48
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.45
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.45
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.43
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 1.43
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.42
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.41
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.4
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.37
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 1.37
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 1.37
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 1.34
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 1.34
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 1.34
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 1.33
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 1.33
Zika virus infection reprograms global transcription of host cells to allow sustained infection 1.3
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.27
scRNASeq analysis of cycling cardiomyocytes 1.26
Effect of ILF3 on translation during homeostasis and the antiviral response 1.25
Dermal endothelial cells of type 2 diabetic patients 1.24
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 1.18
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 1.17
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.17
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.16
RNA-Seq from human ILC transitional populations 1.16
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 1.16
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 1.16
Expression profiling of MCF-7 cells with treatment of TCDD 1.16
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.15
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.15
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 1.15
Human Treg IFNg/IL-10 subpopulations 1.12
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 1.11
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 1.1
Paxillin regulates genomic networks in prostate cancer [C4-2] 1.09
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 1.07
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 1.06
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 1.06
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.05
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.05
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.05
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 1.0
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 0.98
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.98
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.97
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.97
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 0.96
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 0.96
DRB/GRO-Seq -/+ UV 0.94
Transcriptional effect of ETV1 knockdown in melanoma cells 0.93
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 0.91
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 0.91
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.91
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.9
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.9
Effect of nuclear IL-33 on gene expression 0.9
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 0.89
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.89
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.85
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.85
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.84
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.84
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.78
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.77
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.76
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 0.76
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 0.76
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.76
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.75
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.74
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.74
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 0.73
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.73
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.73
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.73
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.71
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.7
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.7
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.7
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.68
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 0.67
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.67
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 0.66
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.65
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.65
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 0.61
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 0.61
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.61
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.59
Human Treg NaCl stimulation 0.58
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.58
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.57
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.55
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.55
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.53
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.52
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.52
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.52
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.52
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.52
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.5
Measure transcript integrity using RNA-seq data 0.49
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.49
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.48
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.46
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.45
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.44
CD73 knockdown effect in pancreatic cancer cell lines 0.44
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.43
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.42
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.41
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.39
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.39
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.37
RNA-Seq and expression data from human adipose tissue 0.37
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.37
Gene expression analysis of human adenomas. 0.36
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 0.33
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.32
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.31
Genome-wide analysis of the Integrator complex (HTS) 0.3
Genome-wide analysis of the Integrator complex 0.3
p63 controls the enhancer landscape during keratinocyte differentiation 0.29
quanTIseq: quantifying immune contexture of human tumors 0.28
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.28
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.27
Function and hormonal regulation of GATA3 in human first trimester placentation 0.25
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 0.25
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.25
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.24
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.23
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.23
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.22
MicroRNA-125a-5p overexpression in human macrophages 0.22
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.21
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 0.21
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.19
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.18
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.14
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.14
The role of the Calcium-Sensing receptor in colorectal cancer 0.12
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.12
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.12
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.11
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 0.09
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.09
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.09
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.09
RNA-seq data 0.08
Downregulation of DDX5/DDX17 and REST 0.08
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.07
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.07
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.07
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 0.06
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.06
The transcriptome and chromatin accessbility landscape of mammalian germline 0.06
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.05
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 0.04
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.04
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.04
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.01
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.01
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.01
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.01
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.01
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation